Electrotherapy Market Size

Global Electrotherapy Market Overview

The Electrotherapy Market Size was valued at USD 0.8 billion in 2022 and is projected to grow from USD 0.83 Billion in 2023 to USD 1.11 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.8% during the forecast period (2023 - 2032). 

Rising frequency of sport injuries and technological advancement and new product launch are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Electrotherapy Market Trends

• Growing Prevalence of sport injuries to boost market growth

The technological advancement, rising obesity, increasing healthcare expenses, and increasing number of sports injuries are the major factors driving the electrotherapy market growth. For instance, as per the National Safety Council (NSC), exercise (with or without equipment) caused roughly 468,000 injuries in 2019, the greatest of any category of sports and entertainment. With over 417,000 injuries, bicycling came in second, while football and basketball came in third and fourth, with 404,000 and 292,000 injuries, respectively. As a result, the market for electrotherapy is driven by the increasing frequency and incidence of sports injuries. Thus driving the market CAGR.

Further, rise in healthcare expenditure also support the market growth of electrotherapy. On 20 February 2019, as per WHO (World Health Organization), global health expenditure, according to which global spending on health rise in low- and middle-income countries by 6% and in high-income countries by 4%. Moreover, besides public expenditure on healthcare, various investments by manufacturers, new products in the global intracranial hemorrhage diagnosis & treatment, venture capitals also expected to drive the growth of the electrotherapy market revenue in the coming years.

Electrotherapy Market Segment Insights

Electrotherapy Treatment Type Insights

The market segments of electrotherapy, based on treatment type, includes extracorporeal shock wave therapy, interferential current therapy, magnetic field therapy, ultrasound therapy, transcutaneous electrical nerve stimulation (TENS) therapy, micro-current therapy. The transcutaneous electrical nerve stimulation (TENS) therapy segment held the majority share in 2022 contribution in respect to the market revenue of electrotherapy. This is primarily owing to the rising prevalence of pain injuries and the increasing number of road accidents across the globe. As per the article published in the prevalence of sports specialization among the young athletes in 2021 was 17% to 41% and the trend is rising globally. Rising sports activities and specialization can increase the risk of injuries related to sports. So electrotherapies such as transcutaneous electrical nerve stimulation (TENS) is commonly used to recover arthritics conditions, neck and back pain, and deep and soft tissues injuries caused by sports, the sports related injuries are expected to rise the demand for TENS globally.

March 2022: In a recent study sponsored by universities acroos the United States and published by the Europeon Pain Federation, the OMRON FocusTM TENS (Transcutaneous Electrical Nerve Stimulation) Therapy for knee (PM-710) device was assessed for its favourable effectiveness in reducing pain for people with mild to moderate knee “wear and tear.” The researchers found that when used during functional tests, such as stair climbing and walking, the OMRAN Focus TENS Therapy for knee was effective in delivering noticeable pain relief.

Electrotherapy Device Type Insights

The Electrotherapy Market segmentation, based on device type, includes transcutaneous electrical neural stimulator (TENS) electronic muscle stimulator (EMS), interferential stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS). The transcutaneous electrical neural stimulator (TENS) segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2032.

Figure 1: Electrotherapy Market, by device type, 2022 & 2032 (USD billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Electrotherapy Application Insights

The Electrotherapy Market data has been bifurcated by application into pain management, neuromuscular dysfunction, urine and fecal incontinence, acute and chronic edema, tissue repair, iontophoresis, orthopedics, and cardiology. The pain management segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The painmanagement segment is rising due to the increasing prevelance of chronic pain and an increase in the approvals and devices launches for pain management. The back and neck pain are increasing due to unhealthy lifestyle, consumption of unhealthy food, and lack of physical movement drives the demand for electrotherapy for the treatment of chronic apin.

October 2022:Parker Laboratories Inc., which manufactures, produces, and sells pain relief creams, institutional cleaners and disinfectants, ultrasound and electromedical contact media, is elaborating its analgesics line. The company has added ne wproducts for pain management such as, Tri-Active Therapy Cream to its HelixTM line, CBD Clinical Cream, and Helix CBD Therapy Cream.

Electrotherapy End User Insights

Based on End Users, the global electrotherapy industry has been segmented into hospital & clinics, rehabilitation centers, long-term care centers, and others. Hospitals & clinics held the largest segment share in 2022, owing to the rapid adoption of advanced electrotherapy technologies, and the availability of skilled medical staff. Moreover, increasing government initiatives to improve the healthcare infrastructure, and the growing number of chronic diseases that cause pain, are the factors due to which the market of electrotherapy is expected to grow during the assessed timeline.

Electrotherapy Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America electrotherapy market accounted for USD 0.36 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing incidence of injuries, rise in surgeries and minimally invasive procedures, as well as increasing hospital admissions across the region.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: ELECTROTHERAPY MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe electrotherapy market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an ageing population, and an increase in incidence of chronic diseases, and high healthcare spending. Further, the Germany market of electrotherapy held the largest market share, and the UK market of electrotherapy was the fastest growing market in the European region.

The Asia-Pacific electrotherapy Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to increased rates of neuropathy and other related disorders, government initiatives, growing aged population, rising patients of neurology related pain disorders, increasing diabetic patients. Moreover, China market of electrotherapy held the largest market share, and the India market of electrotherapy was the fastest growing market in the Asia-Pacific region.

Electrotherapy Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market growth of electrotherapy. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the electrotherapy industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global electrotherapy industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, electrotherapy industry has provided medicine with some of the most significant benefits. The electrotherapy market major player such as Medtronic plc (Ireland), Alimed, Cogentix Medical, Jude Medical, Zynex Medical(US), DJO Global Inc. (US), Livanova Plc (UK), Nervo Corp (US), Neuromextrix Inc. (US), Boston Scientific Corporation (US), and others are working to expand the market demand by investing in research and development activities.

NeuroMetrix Inc. (US) is an innovation-driven organization focused on the global commercialization and development of non-invasive medical devices for the treatment and diagnosis of pain and neurological disorders. In September 2020, NeuroMetrix Inc. launched an app named Quell for Apple Watch, the first smartwatch app for an over-the counter pain relief device.

Also, Boston Scientific Corporation (US) is a company committed to change lives through innovative medical solutions that recover the health of patients. In January 2019, Boston Scientific Corportaion launched Vercise Gevia Deep Brain Stimulation (DBS) Systmes and Versice Primary Cell (PC). These two systems help physicians to control the range, position, shape, and direction of stimulation to treat Parkinson’s disease (PD) symptoms through highly modified therapy.

Key Companies in the market of Electrotherapy includes

• Medtronic Inc (Ireland)


• Alimed


• Cogentix Medical


• Jude Medical


• Zynex Medical (US)


• DJO Global Inc. (US)


• Livanova Plc (UK)


• Nervo Corp (US)


• Neuromextrix Inc. (US)


• Boston Scientific Corporation (US), among others

Electrotherapy Industry Developments

February 2024: Enovis, a medical technology business focused on innovation, announced the release of two new products: Intelect Legend 2 and Intelect Transport 2. These products are part of Enovis Recovery Sciences' Chattanooga electrotherapy portfolio and the firm's wide range of rehabilitation solutions. The American Physical Therapy Association's (APTA) Combined Sections Meeting, scheduled for February 15-17, 2024 in Boston, will showcase these cutting-edge innovations. Both Legend 2 and Transport 2 are driven by VMS, a Chattanooga exclusive waveform. The configuration of this waveform facilitates enhanced muscular contractions, reduced patient discomfort, and diminished neural exhaustion. The selection of waveform is crucial in determining the therapeutic results in the field of electrical muscle stimulation. The VMS waveform, characterized by its distinctive alternating frequency pattern, provides numerous advantages compared to conventional waveforms.

July 2021: the Penn Brain Science, Translation, Innovation, and Modulation (brainSTIM) Center was established. This center is unique in the region as it brings together a team of prominent neuroscientists, neurologists, psychiatrists, psychologists, and engineers from the University of Pennsylvania. The primary focus of the center is to utilize neuromodulation techniques to study, restore, and improve human brain function. The center will serve as a focal point for the advancement of novel therapies that employ neuromodulation, which involves the direct application of electrical signals or magnets to the brain, with the aim of reestablishing, reconfiguring, and reinstating brain function in individuals afflicted with diverse neurologic conditions such as dementia and stroke, as well as psychiatric disorders like anxiety. The facility employs several neuromodulation techniques, such as transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES). By integrating these technologies with sophisticated imaging methods, such as structural and functional magnetic resonance imaging, specialists can investigate crucial connections between brain structure and function that are fundamental to human cognition and neural activity.

January 2021:The WaveWriter Alpha is a portfolio of spinal cord stimulator (SCS) devices from Boston Scientific Corporation that combines therapeutic choices for individualized pain alleviation.

November 2020:DJO Global is a medical device company that manufactures a variety of orthopedic products for pain management, rehabilitation, and physical therapy join hands with XPO Logistics (US) and opened a distribution center in Dallas and Texas.

Electrotherapy Market Segmentation

Electrotherapy Treatment Type Outlook

• Extracorporeal Shock Wave Therapy


• Interferential Current Therapy (IC)


• Magnetic Field Therapy


• Ultrasound Therapy


• Transcutaneous Electrical Nerve Stimulation (TENS) Therapy


• Micro-Current Therapy

Electrotherapy Device Type Outlook

• Transcutaneous Electrical Neural Stimulation (TENS)


• Electronic Muscle Stimulator (EMS)


• Interferential Stimulator (IF)


• High Voltage Pulsed Galvanic Stimulator (HVPGS)

Electrotherapy Application Outlook

• Pain Management


• Neuromuscular Dysfunction


• Urine and Fecal Incontinence


• Acute and Chronic Edema


• Tissue Repair


• Iontophoresis


• Orthopedics


• Cardiology

Electrotherapy End User Outlook

• Hospitals & Clinics


• Rehabilitation Centers


• Long Term Centers

Electrotherapy Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America